Objectives To study the outcome of chromosomally normal pregnancies with increased nuchal translucency at the 10-14-week scan.
INTRODUCTION
The measurement of fetal nuchal translucency (NT) thickness at 10 -14 weeks of gestation has been established as a sensitive, accurate and effective method of screening for chromosomal abnormalities 1 . In addition, several studies have reported on the association of increased NT with major cardiac defects 2 , other structural defects and rare genetic syndromes 3 . In a screening study involving 96 127 singleton pregnancies, the incidence of chromosomal defects increased with fetal NT thickness 1 (Table 1) . A study of 693 chromosomally normal pregnancies with a fetal NT of at least 3.5 mm, which represents the 99th centile of the normal range, reported on the prevalence of adverse outcome, including major structural abnormalities and genetic syndromes 3 . This study is an expanded series of 1320 chromosomally normal fetuses with increased NT providing data on the prevalence of adverse outcome, which is examined in relation to both the measurement of fetal NT and the findings of the follow-up ultrasound scans.
METHODS
The Harris Birthright Research Centre for Fetal Medicine is a tertiary referral center. Patients found to have increased NT at the routine first-trimester scan in their local hospitals are referred for a detailed first-trimester anomaly scan, counseling and invasive tests for fetal karyotyping. The first-trimester scan includes measurement of the crown-rump length and NT as previously described 4 and ultrasound examination of the following structures: skull, brain, chest, abdominal wall, stomach, bladder and upper and lower extremities. In pregnancies with increased NT and normal karyotype we recommend follow-up scans at 16 and 20 weeks of gestation and (64.45) from 1998 these patients have also had specialist fetal echocardiography. The follow-up scans are performed at the Harris Birthright Centre in the majority of cases. However, some women opt to have follow up at their local hospitals. Demographic details and ultrasound findings were entered into a computer database at the time of scanning. Karyotype results and details of pregnancy outcome were entered as soon as they became available. Pregnancy outcome was obtained from the maternity units, the general practitioners or the patients themselves. Details on follow-up ultrasound scans were obtained from the Harris Birthright database or the obstetric ultrasound units if the follow-up scans were carried out locally.
A computer search was carried out to identify all singleton pregnancies with live fetuses and crown-rump length of 38-84 mm, NT of ≥ 3.5 mm, normal karyotype (or birth of a child with no features suggestive of chromosomal abnormality), estimated date of delivery before 1 July 2000 and known pregnancy outcome.
The prevalence of adverse pregnancy outcome (including miscarriage, intrauterine death, postnatal death or survival with mental handicap or defects requiring medical or surgical treatment) was calculated according to the NT measurement from the first-trimester scan. Minor structural defects, such as mild hydronephrosis, choroid plexus cysts, digital anomalies and cardiac defects not requiring treatment were not included in the calculations.
A review of the literature was carried out to determine the reported defects in chromosomally normal fetuses with increased NT thickness at 10-14-weeks of gestation. In addition, a search was made for studies reporting the diagnosis of fetal abnormalities at the 10-14-week scan and these studies were examined to identify the conditions that were associated with increased NT thickness.
RESULTS
The computer search identified 1320 chromosomally normal singleton pregnancies with NT ≥ 3.5 mm at a median gestation of 12 weeks (range, 10-14 weeks). The data of the first 693 fetuses that were previously reported by Souka et al. 3 are included in the present study.
The outcome of the 1320 pregnancies is summarized in Table 2 . There were 68 (5.15%) spontaneous abortions or intrauterine deaths (Table 3) , 18 (1.36%) neonatal and infant deaths (Table 4 ) and 154 (11.67%) terminations of pregnancy. The indications for termination of pregnancy were prenatal diagnosis of fetal abnormalities (n = 102), progressive fetal hydrops (n = 15) and parental request (n = 37). Of the 1080 (81.82%) survivors, 60 (5.56%) had abnormalities requiring medical or surgical treatment or leading to mental handicap. In total there were 200 (15.15%) cases with abnormalities and the condition was diagnosed prenatally in 162 (80.50%) cases (Table 5) .
From the study group of 1320 pregnancies, 1137 had follow-up scans at 15 and/or 20 weeks of gestation; in the remaining 183 cases there was pregnancy termination or miscarriage before 15 weeks in 128 cases and between 15 and 20 weeks in 55 cases. In the group of the 1137 cases that were available for follow up, ultrasound examination demonstrated fetal defects in 75 cases, persistent nuchal edema in 82 cases (including six cases with generalized edema, ascites and / or pericardial effusion) and in 980 cases the sonographic examination was unremarkable (Table 6 ). In 16 of the 75 cases with structural defects, persistent nuchal edema was also present.
In the group of 82 pregnancies with apparently isolated and persistent nuchal edema, 15 (18.29%) cases had an adverse outcome (Table 7 ). In the group of 980 pregnancies without abnormal findings at the follow-up scans, there were 22 (2.24%) cases of adverse outcome ( Table 8 ). The prevalence of severe developmental delay was 1.22% (1/82) and 0.41% (4/980) in the groups of persistent nuchal edema and normal follow-up, respectively. Specialist fetal echocardiography was not offered to patients in the early part of the study and during this period nine detectable cardiac defects were not diagnosed prenatally. If these cardiac defects had been excluded from the analysis, the rate of unexpected adverse outcome would have been 14.10% and 1.74% in the groups with persistent nuchal edema and normal follow up, respectively. The conditions that were identified by the literature search to be associated with increased NT are summarized in Table 9 5-72
.
DISCUSSION
This study provides further evidence that in chromosomally normal fetuses the risk of miscarriage, intrauterine death, diagnosis of major structural defects leading to termination of pregnancy, postnatal death or survival with defects, increases with increasing NT (Table 2) . Consequently, in counseling parents with pregnancies with increased NT, the chance of an adverse outcome, including chromosomal defects (Table 1) , in the group with a NT of 3.5-4.4 mm is 32%, for those with a NT of 4.5-5.4 mm it is 49%, for those with a NT of 5.5-6.4 mm it is 67%, and for those with a NT of ≥ 6.5 mm it is 89% (Figure 1 ).
There is a wide range of conditions that have been reported in fetuses with increased NT (Tables 5 and 9 ). Although in some cases the defect may be purely coincidental, in other cases there may be a true association operating through one or more of the following mechanisms: cardiac dysfunction in association with abnormalities of the heart and great arteries; venous congestion in the head and neck in association with the constriction of the fetal body in amnion rupture sequence or superior mediastinal compression found in diaphragmatic hernia or the narrow chest in skeletal dysplasia; failure of lymphatic drainage due to abnormal or delayed development of the lymphatic system or impaired fetal movements in Table 6 Adverse Nuchal translucency, structural defects and genetic syndromes Souka et al. There is strong evidence on the association between increased NT and trisomy 21 as well as all other major chromosomal abnormalities (Table 1) . Consequently, the first line of management of such pregnancies should be the offer of fetal karyotyping. In the chromosomally normal group the parents should be counseled that even if the NT is more than 6.5 mm there is a one in three chance that the pregnancy would result in a live birth with no major defects ( Table 2) . Nevertheless, the association between increased NT and a wide range of structural abnormalities and genetic syndromes (Table 9 ) constitutes an indication for detailed follow-up scans, including fetal echocardiography, and possibly further genetic testing (Figure 2) . Specialist echocardiography and anomaly scanning can lead to the diagnosis of many fetal abnormalities from as early as 12 weeks 73 . Following chorionic villus sampling and exclusion of a chromosomal abnormality, a follow-up scan at 14-16 weeks would determine the evolution of the NT and diagnose or exclude many fetal defects.
Persistence of unexplained NT or evolution to hydrops fetalis raises the possibility of congenital infection or a genetic syndrome 74 . In this study nuchal edema was considered to be present if in the midsagittal plane of the neck there was subcutaneous edema that produced a characteristic tremor on ballotment of the fetal head 74 . As shown in Table 5 , a significant number of genetic conditions, such as spinal muscular atrophy, are now amenable to prenatal diagnosis by DNA testing and it would therefore be possible to undertake such testing in the chorionic villus sample that has already been obtained for fetal karyotyping. The diagnosis of congenital infection can be investigated by maternal serum infection screening. Sebire et al. investigated the possibility of infection in 426 Nuchal translucency, structural defects and genetic syndromes Souka et al. chromosomally normal pregnancies with increased fetal NT thickness at 10-14 weeks of gestation and 63 with 'unexplained' second-or third-trimester fetal nuchal edema or hydrops 75 . Evidence of recent maternal infection was present in six (1.4%) of the 426 pregnancies with increased fetal NT but in all cases a healthy infant was born with no evidence of infection. In contrast, 'unexplained' second-or third-trimester fetal hydrops was associated with maternal infection in six (9.5%) of the pregnancies and in all cases there was evidence of fetal infection.
The series of investigations suggested above would have identified the majority of conditions associated with adverse outcome in fetuses with increased NT. In those cases with no obvious abnormalities identified by 20 weeks of gestation, the parents can be counseled that the risk of an adverse outcome is very small. In the group of 980 pregnancies without abnormal findings at the follow-up scans, there were 22 (2.24%) cases of adverse outcome, including five with cardiac defects that are amenable to prenatal diagnosis by specialist fetal echocardiography (Tables 6 and 8) . Although in patients with apparently unexplained nuchal edema at the 20-week scan, 18% had an adverse outcome, one third of these had potentially detectable cardiac defects, one third progressed to hydrops or resulted in unexplained intrauterine death and only one third resulted in live births with genetic syndromes, such as Noonan syndrome or Finnish nephrosis (Tables 6 and 7 ). In our study the prevalence of neurodevelopmental delay in the group with normal follow-up scans was 0.4% and in those with persistent nuchal edema it was 1.2%. In two previous studies of 63 and 38 pregnancies with increased NT, the prevalence of neurodevelopmental delay was 3.2% and 5.6%, respectively, 5, 20 . However, we acknowledge that the true prevalence of neurodevelopmental delay is likely to be underestimated because many such cases may not become apparent until several years after birth.
Increased fetal NT is associated with chromosomal abnormalities, many fetal defects and genetic syndromes. In the majority of cases the proposed series of antenatal investigations can help distinguish between the pregnancies destined to result in adverse outcome and those leading to the delivery of infants with no major defects. 
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